 |
PDBsum entry 1nop
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/DNA
|
PDB id
|
|
|
|
1nop
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/DNA
|
 |
|
Title:
|
 |
Crystal structure of human tyrosyl-DNA phosphodiesterase (tdp1) in complex with vanadate, DNA and a human topoisomerase i-derived peptide
|
|
Structure:
|
 |
5'-d( Ap Gp Ap Gp Tp T)-3'. Chain: d, f. Engineered: yes. Tyrosyl-DNA phosphodiesterase 1. Chain: a, b. Fragment: residues 149-608. Synonym: tdp1. Engineered: yes. Mutation: yes.
|
|
Source:
|
 |
Synthetic: yes. Other_details: this sequence is derived from a sequence known to be a target for topoisomerase i. Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Other_details: this sequence occurs naturally in human topoisomerase
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.208
|
R-free:
|
0.252
|
|
|
Authors:
|
 |
D.R.Davies,H.Interthal,J.J.Champoux,W.G.J.Hol
|
Key ref:
|
 |
D.R.Davies
et al.
(2003).
Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide.
Chem Biol,
10,
139-147.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
16-Jan-03
|
Release date:
|
11-Mar-03
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9NUW8
(TYDP1_HUMAN) -
Tyrosyl-DNA phosphodiesterase 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
608 a.a.
425 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 3 residue positions (black
crosses)
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Chem Biol
10:139-147
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide.
|
|
D.R.Davies,
H.Interthal,
J.J.Champoux,
W.G.Hol.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Tyrosyl-DNA phosphodiesterase (Tdp1) is a member of the phospholipase D
superfamily and acts as a DNA repair enzyme that removes stalled topoisomerase
I- DNA complexes by hydrolyzing the bond between a tyrosine side chain and a DNA
3' phosphate. Despite the complexity of the substrate of this phosphodiesterase,
vanadate succeeded in linking human Tdp1, a tyrosine-containing peptide, and a
single-stranded DNA oligonucleotide into a quaternary complex that mimics the
transition state for the first step of the catalytic reaction. The conformation
of the bound substrate mimic gives compelling evidence that the topoisomerase
I-DNA complex must undergo extensive modification prior to cleavage by Tdp1. The
structure also illustrates that the use of vanadate as the central moiety in
high-order complexes has the potential to be a general method for capturing
protein-substrate interactions for phosphoryl transfer enzymes, even when the
substrates are large, complicated, and unusual.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Hydrogen Bonding Contacts between Tdp1 and the
Vanadate-Peptide-DNA Substrate Transition State AnalogTdp1,
peptide, and DNA are colored as in Figure 1A, with the vanadate
moiety in green and hydrogen bonds indicated by dashed lines.
Residues 232–242 of Tdp1 have been omitted for clarity.
Hydrogen bonds to the vanadate moiety are displayed in (A),
hydrogen bonds to the peptide moiety are displayed in (B), and
hydrogen bonds to the DNA moiety in (C).
|
 |
Figure 4.
Figure 4. Electrostatic Potential Surface of Tdp1The
molecular surface is colored between −10kT (red) and +10kT
(blue) and was generated with the program GRASP [35]. The
orientation of the Tdp1 structure is the same as in Figure 1A.
The peptide-vanadate-DNA substrate mimic is displayed as a stick
structure. The yellow V indicates the position of the vanadate
residue in the active site. The DNA moiety extends above the
active site, bound in the narrow, positively charged half of the
substrate binding groove. The peptide moiety is located below
the active site in a relatively neutral portion of the wider
substrate binding cleft.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Chem Biol
(2003,
10,
139-147)
copyright 2003.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Shi,
K.Kurahashi,
R.Gao,
S.E.Tsutakawa,
J.A.Tainer,
Y.Pommier,
and
H.Aihara
(2012).
Structural basis for recognition of 5'-phosphotyrosine adducts by Tdp2.
|
| |
Nat Struct Mol Biol,
19,
1372-1377.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.A.Nair,
P.Smith,
and
S.Shuman
(2010).
Structure of bacterial LigD 3'-phosphoesterase unveils a DNA repair superfamily.
|
| |
Proc Natl Acad Sci U S A,
107,
12822-12827.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.S.Dexheimer,
A.G.Stephen,
M.J.Fivash,
R.J.Fisher,
and
Y.Pommier
(2010).
The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.
|
| |
Nucleic Acids Res,
38,
2444-2452.
|
 |
|
|
|
|
 |
I.Nielsen,
I.B.Bentsen,
M.Lisby,
S.Hansen,
K.Mundbjerg,
A.H.Andersen,
and
L.Bjergbaek
(2009).
A Flp-nick system to study repair of a single protein-bound nick in vivo.
|
| |
Nat Methods,
6,
753-757.
|
 |
|
|
|
|
 |
T.S.Dexheimer,
L.K.Gediya,
A.G.Stephen,
I.Weidlich,
S.Antony,
C.Marchand,
H.Interthal,
M.Nicklaus,
R.J.Fisher,
V.C.Njar,
and
Y.Pommier
(2009).
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
|
| |
J Med Chem,
52,
7122-7131.
|
 |
|
|
|
|
 |
A.González Baró,
I.Andersson,
L.Pettersson,
and
A.Gorzsás
(2008).
Speciation in the aqueous peroxovanadate-maltol and (peroxo)vanadate-uridine systems.
|
| |
Dalton Trans,
(),
1095-1102.
|
 |
|
|
|
|
 |
T.S.Dexheimer,
S.Antony,
C.Marchand,
and
Y.Pommier
(2008).
Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.
|
| |
Anticancer Agents Med Chem,
8,
381-389.
|
 |
|
|
|
|
 |
C.Liu,
S.Zhou,
S.Begum,
D.Sidransky,
W.H.Westra,
M.Brock,
and
J.A.Califano
(2007).
Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer.
|
| |
Lung Cancer,
55,
303-311.
|
 |
|
|
|
|
 |
S.Antony,
C.Marchand,
A.G.Stephen,
L.Thibaut,
K.K.Agama,
R.J.Fisher,
and
Y.Pommier
(2007).
Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1.
|
| |
Nucleic Acids Res,
35,
4474-4484.
|
 |
|
|
|
|
 |
J.T.Reardon,
and
A.Sancar
(2006).
Repair of DNA-polypeptide crosslinks by human excision nuclease.
|
| |
Proc Natl Acad Sci U S A,
103,
4056-4061.
|
 |
|
|
|
|
 |
K.C.Nitiss,
M.Malik,
X.He,
S.W.White,
and
J.L.Nitiss
(2006).
Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage.
|
| |
Proc Natl Acad Sci U S A,
103,
8953-8958.
|
 |
|
|
|
|
 |
Y.Pommier,
J.M.Barcelo,
V.A.Rao,
O.Sordet,
A.G.Jobson,
L.Thibaut,
Z.H.Miao,
J.A.Seiler,
H.Zhang,
C.Marchand,
K.Agama,
J.L.Nitiss,
and
C.Redon
(2006).
Repair of topoisomerase I-mediated DNA damage.
|
| |
Prog Nucleic Acid Res Mol Biol,
81,
179-229.
|
 |
|
|
|
|
 |
A.C.Raymond,
B.L.Staker,
and
A.B.Burgin
(2005).
Substrate specificity of tyrosyl-DNA phosphodiesterase I (Tdp1).
|
| |
J Biol Chem,
280,
22029-22035.
|
 |
|
|
|
|
 |
H.Interthal,
H.J.Chen,
and
J.J.Champoux
(2005).
Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages.
|
| |
J Biol Chem,
280,
36518-36528.
|
 |
|
|
|
|
 |
H.Interthal,
H.J.Chen,
T.E.Kehl-Fie,
J.Zotzmann,
J.B.Leppard,
and
J.J.Champoux
(2005).
SCAN1 mutant Tdp1 accumulates the enzyme--DNA intermediate and causes camptothecin hypersensitivity.
|
| |
EMBO J,
24,
2224-2233.
|
 |
|
|
|
|
 |
H.Zhu,
L.K.Wang,
and
S.Shuman
(2005).
Essential constituents of the 3'-phosphoesterase domain of bacterial DNA ligase D, a nonhomologous end-joining enzyme.
|
| |
J Biol Chem,
280,
33707-33715.
|
 |
|
|
|
|
 |
T.Biswas,
H.Aihara,
M.Radman-Livaja,
D.Filman,
A.Landy,
and
T.Ellenberger
(2005).
A structural basis for allosteric control of DNA recombination by lambda integrase.
|
| |
Nature,
435,
1059-1066.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.R.Ferré-D'Amaré
(2004).
The hairpin ribozyme.
|
| |
Biopolymers,
73,
71-78.
|
 |
|
|
|
|
 |
H.U.Barthelmes,
M.Habermeyer,
M.O.Christensen,
C.Mielke,
H.Interthal,
J.J.Pouliot,
F.Boege,
and
D.Marko
(2004).
TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II.
|
| |
J Biol Chem,
279,
55618-55625.
|
 |
|
|
|
|
 |
J.C.Connelly,
and
D.R.Leach
(2004).
Repair of DNA covalently linked to protein.
|
| |
Mol Cell,
13,
307-316.
|
 |
|
|
|
|
 |
M.C.Rideout,
A.C.Raymond,
and
A.B.Burgin
(2004).
Design and synthesis of fluorescent substrates for human tyrosyl-DNA phosphodiesterase I.
|
| |
Nucleic Acids Res,
32,
4657-4664.
|
 |
|
|
|
|
 |
S.S.Martin,
S.Wachi,
and
E.P.Baldwin
(2003).
Vanadate-based transition-state analog inhibitors of Cre-LoxP recombination.
|
| |
Biochem Biophys Res Commun,
308,
529-534.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |